Thimerosal News and Research

RSS

Wyeth wins Maryland thimerosal autism case

Wyeth has announced that The Honorable Stuart R. Berger of the Circuit Court for Baltimore City in Baltimore, Maryland, has granted Wyeth's motion for summary judgment in the case of Blackwell, et al. v. Sigma Aldrich, Inc., et al - an alleged vaccine injury case claiming that Jamarr Blackwell's exposure to thimerosal-containing vaccines caused him to become autistic.

20 Feb 2008

Infants' bodies expel thimerosal mercury much faster than originally thought

February's issue of Pediatrics offers another reason to rethink blaming the spike in autism diagnoses on thimerosal, a mercury-containing preservative routinely used in several childhood vaccines until the late '90s.

4 Feb 2008

Cell signaling in cervical cancer; gene variant impairs glycogen synthesis

The March of Dimes and seven former directors of the U.S. Centers for Disease Control and Prevention (CDC) today urged parents not to be frightened of childhood vaccines by the suggestion in an upcoming episode of the ABC-TV drama, "Eli Stone" that the mercury-based preservative thimerosal -- which is no longer used in vaccines may lead to autism.

30 Jan 2008

Maryland Court rejects Thimerosal - autism link

Wyeth has announced that The Honorable Stuart R. Berger of the Circuit Court for Baltimore City in Baltimore, Maryland, has granted Wyeth's motion to preclude plaintiffs' expert witnesses in an alleged vaccine injury case from testifying that exposure to thimerosal-containing vaccines can cause autism..

16 Jan 2008

Controversy over autism and childhood vaccines settled once and for all

The results of a new study into the link between childhood vaccines and autism may settle once and for all the controversy over the issue.

7 Jan 2008

FDA approves Afluria in time for flu season

The U.S. Food and Drug Administration today approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older.

29 Sep 2007

Study says childhood vaccine component thimerosal not linked to neuropsychological problems

According to the latest research on the affect of thimerosal (mercury) in vaccines on the neuropsychological functions of children's brains, the evidence suggests there is no association.

27 Sep 2007

Sanofi pasteur ships doses of Fluzone influenza vaccine for the 2007-2008 season

Sanofi pasteur, the vaccines division of the sanofi-aventis Group, has begun shipment of influenza vaccine (Fluzone, Influenza Virus Vaccine) in the United States for the 2007-2008 season.

13 Aug 2007

Autism - MMR vaccine has it's day in court

A test case in an American court could in one way or another settle the debate on the possible link between autism and childhood vaccines.

11 Jun 2007

Mercury's link to heart disease

Heavy metals and other toxins have been linked to many human diseases, but determining exactly how they damage the body remains a mystery in many cases.

1 Jun 2007

Lack of association between Rh status, Rh immune globulin in pregnancy and autism

The increase in the number of diagnosed cases of autism in recent years has sparked concern that environmental toxins may cause this complex disorder.

17 May 2007

Environmental toxins may cause autism

The increase in the number of diagnosed cases of autism in recent years has sparked concern that environmental toxins may cause this complex disorder.

17 May 2007

CSL Biotherapies submits Biologics License Application to FDA

Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.S. marketplace. The company's BLA requests that the vaccine be approved to immunize people 18 years of age and older.

3 Apr 2007

Vaccines again linked to form of autism

New findings presented yesterday at a National Autism Association meeting bolster claims that vaccines may play a role in the development of autism spectrum disorders.

8 Mar 2007

Thimerosal to be discussed at Wednesday's CDC meeting

The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am.

19 Feb 2007

FDA approves MedImmune's new refrigerated formulation of FluMist influenza virus vaccine

MedImmune has announced that the U.S. Food and Drug Administration (FDA) has approved the company's new refrigerated formulation of FluMist (Influenza Virus Vaccine Live, Intranasal) for use in helping to prevent influenza in healthy children and adults from 5 years to 49 years of age.

8 Jan 2007

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006